| Phase II study of viscum fraxini-2 in patients with advanced hepatocellular carcinoma M Mabed, L El-Helw, S Shamaa British journal of cancer 90 (1), 65-69, 2004 | 90 | 2004 |
| Thrombopoietin (TPO) levels in hepatic patients with thrombocytopenia S Aref, M Mabed, T Selim, T Goda, N Khafagy Hematology 9 (5-6), 351-356, 2004 | 62 | 2004 |
| A randomized controlled trial of transcatheter arterial chemoembolization with lipiodol, doxorubicin and cisplatin versus intravenous doxorubicin for patients with unresectable … M Mabed, M Esmaeel, T El‐Khodary, M Awad, T Amer European journal of cancer care 18 (5), 492-499, 2009 | 49 | 2009 |
| Urokinase plasminogen activator receptor and soluble matrix metalloproteinase-9 in acute myeloid leukemia patients: a possible relation to disease invasion S Aref, M El-Sherbiny, M Mabed, A Menessy, M El-Refaei Hematology 8 (6), 385-391, 2003 | 48 | 2003 |
| Mesenchymal stem cell-based therapy for the treatment of type 1 diabetes mellitus M Mabed, M Shahin Current stem cell research & therapy 7 (3), 179-190, 2012 | 45 | 2012 |
| The interplay between c-Myc oncogene expression and circulating vascular endothelial growth factor (sVEGF), its antagonist receptor, soluble Flt-1 in diffuse large B cell … S Aref, M Mabed, K Zalata, M Sakrana, H El Askalany Leukemia & lymphoma 45 (3), 499-506, 2004 | 33 | 2004 |
| Increased expression of costimulatory molecules CD86 and sCTLA-4 in patients with acute lymphoblastic leukemia A Mansour, T Elkhodary, A Darwish, M Mabed Leukemia & Lymphoma 55 (9), 2120-2124, 2014 | 32 | 2014 |
| Interleukin-1 administration before lethal irradiation and allogeneic bone marrow transplantation: early transient increase of peripheral granulocytes and successful … P Tiberghien, V Laithier, M Mabed, E Racadot, CW Reynolds, R Angonin, ... | 30 | 1993 |
| Cyclin D1 expression in acute leukemia S Aref, M Mabed, M El-Sherbiny, T Selim, A Metwaly Hematology 11 (1), 31-34, 2006 | 28 | 2006 |
| Potential utility of antineoplaston A-10 levels in breast cancer F Badria, M Mabed, W Khafagy, L Abou-Zeid Cancer letters 155 (1), 67-70, 2000 | 28 | 2000 |
| c-Myc oncogene and Cdc25A cell activating phosphatase expression in non-Hodgkin’s lymphoma S Aref, M Fouda, E El-Dosoky, A Menessy, M Mabed, M Saleeb, K Zalata Hematology 8 (3), 183-190, 2003 | 26 | 2003 |
| Chlorambucil plus theophylline vs chlorambucil alone as a front line therapy for B-cell chronic lymphatic leukemia M Mabed, S Aref, M Fouda, S El-Sharawy Leukemia & lymphoma 45 (10), 2029-2035, 2004 | 25 | 2004 |
| Immune modulatory potentials of antineoplaston A-10 in breast cancer patients F Badria, M Mabed, M El-Awadi, L Abou-Zeid, E Al-Nashar, S Hawas Cancer letters 157 (1), 57-63, 2000 | 24 | 2000 |
| Prognostic significance of absolute lymphocyte count, absolute monocyte count, and absolute lymphocyte count to absolute monocyte count ratio in follicular non-Hodgkin lymphoma A Mohsen, M Taalab, N Abousamra, M Mabed Clinical Lymphoma Myeloma and Leukemia 20 (9), e606-e615, 2020 | 22 | 2020 |
| Soluble hepatocyte growth factor (sHGF) and vascular endothelial growth factor (sVEGF) in adult acute myeloid leukemia: relationship to disease characteristics S Aref, M Mabed, M Sakrana, T Goda, M El-Sherbiny Hematology 7 (5), 273-279, 2002 | 22 | 2002 |
| Prognostic impact of CD200 and CD56 expression in adult acute lymphoblastic leukemia patients S Aref, E Azmy, K El-Bakry, L Ibrahim, M Mabed Hematology 23 (5), 263-270, 2018 | 17 | 2018 |
| Systematic review of purine analog treatment for chronic lymphocytic leukemia: lessons for future trials. CLLTC Group Haematologica. 97 (3), 428-36., 2012 | 17 | 2012 |
| Clinical significance of CD200 and CD56 expression in patients with acute myeloid leukemia S Aref, N Abousamara, E El-Helaly, M Mabed Asian Pacific Journal of Cancer Prevention: APJCP 21 (3), 743, 2020 | 16 | 2020 |
| High-dose chemotherapy plus non-cryopreserved autologous peripheral blood stem cell transplantation rescue for patients with refractory or relapsed Hodgkin disease M Mabed, S Shamaa Biology of Blood and Marrow Transplantation 12 (9), 942-948, 2006 | 16 | 2006 |
| The potential utility of bone marrow or umbilical cord blood transplantation for the treatment of type I diabetes mellitus M Mabed Biology of Blood and Marrow Transplantation 17 (4), 455-464, 2011 | 15 | 2011 |
Sameh ShamaaProfessor of Medical Oncology, Mansoura University,EgyptVerified email at mans.edu.eg
